4UPJ | Hydrolase (Acid Protease) | date | Mar 04, 1996 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Immunodeficiency Virus Type 2 Protease Mutant With Lys Replaced By Leu (K57l) Complex With U097410 [4-Hydroxy-3-[1 [[[[(Tert-Butyloxycarbonyl) Aminomethyl]Carbonyl]Amino]Phenyl]Propyl]Coumarin | ||||||||||||||
authors | K.D.Watenpaugh, A.M.Mulichak, M.N.Janakiraman | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Hiv-2 Protease Chain: A, B Ec: 3.4.23.16 Engineered: Yes Mutation: Yes |
Organism_scientific: Human Immunodeficiency Virus 2 Organism_taxid: 11709 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | U04 | enzyme | Hydrolase E.C.3.4.23.16 BRENDA | ||||||||||||
related structures | by homologous chain: 1HSH, 2HPE | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors., Thaisrivongs S, Watenpaugh KD, Howe WJ, Tomich PK, Dolak LA, Chong KT, Tomich CC, Tomasselli AG, Turner SR, Strohbach JW, et al., J Med Chem 1995 Sep 1;38(18):3624-37. PMID:7658450 |
Data retrieval |
View 4UPJ in 3D |
Visual 3D analysis of 4UPJ |
Structure-derived information |
- Domain d4upja_, region A [Jmol] [rasmolscript] [script source] - Domain d4upjb_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 4UPJ |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |